New drug DW4421 put through safety check with NSAIDs in healthy volunteers
NCT ID NCT07343245
First seen Jan 17, 2026 · Last updated Jun 23, 2026 · Updated 23 times
Summary
This early-stage trial is testing an experimental drug called DW4421 alongside three different NSAID painkillers in 150 healthy adults aged 19 to 50. The goal is to see how the drugs interact and whether the combination is safe. Participants will take DW4421 alone or with one of the NSAIDs, and researchers will measure drug levels in the blood and monitor for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chungbuk National University Hospital
RECRUITINGCheongju-si, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DW4421 (an experimental drug) and three NSAIDs
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.